Capturing conversations between AAM leadership and members, thought leaders, legislators and others about topics that intersect the generics and biosimilars space.
Today we're here in Orlando, Florida during our Annual Meeting, ACCESS! We're talking with Alok Sonig, CEO, US Generics, and Head of Global R&D & Biosimilars at Lupin Incorporated.
Like the episode on your phone
Download Free Podcast App
Play this podcast on Podbean App